Tashkent, Uzbekistan (UzDaily.uz) — Turkish pharmaceutical company Nobel İlaç has discussed potential cooperation and opportunities to participate in Uzbekistan's pharmaceutical industry projects, the Agency for the Development of the Medical and Pharmaceutical Industry said.
On 17 November, agency director Abdulla Azizov met Nobel İlaç Chairman Hasan Ulusoy and other company representatives.
The Uzbek side presented the development plans for the BioPharma City pharmaceutical cluster, its emerging infrastructure and opportunities for international manufacturers.
The cluster is being developed as an integrated ecosystem combining pharmaceutical production, scientific and clinical research, and specialist training for the industry.
The Turkish delegation reviewed BioPharma City's main development areas, infrastructure and conditions for locating manufacturing facilities.
The participants also discussed expanding research and development capacity, developing new medicines and attracting international companies to build a modern biopharmaceutical industry.
Another topic was the development of Uzbekistan's pharmaceutical market and Nobel İlaç's potential participation in future projects in the country.